News Focus
News Focus
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: iclight post# 212725

Monday, 02/04/2019 5:22:43 PM

Monday, February 04, 2019 5:22:43 PM

Post# of 822564

Problem is, no clue if it had anything to do with the actual treatment. Just like NWBO.



I would suggest it is to to do with treatment.
Because you just do not get anything like those stats with SOC.

Merck has no problems getting approvals from small uncontrolled single-arm open-label trials that say more about toxicity than they do about survival.

There is little correlation between whether a drug works or not, and whether it is safe or toxic, and whether it is approved!

But that's the good old FDA for you...

If DCVaxL fails to gain approval, it won't be because it doesn't work.

Just my humble opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News